SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-220556
Filing Date
2024-09-17
Accepted
2024-09-17 16:21:54
Documents
22
Period of Report
2024-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d877593d8k.htm   iXBRL 8-K 33343
2 EX-1.1 d877593dex11.htm EX-1.1 202452
3 EX-5.1 d877593dex51.htm EX-5.1 9278
4 EX-99.1 d877593dex991.htm EX-99.1 10051
8 GRAPHIC g877593dsp49.jpg GRAPHIC 969
9 GRAPHIC g877593dsp49a.jpg GRAPHIC 1037
10 GRAPHIC g877593g00n71.jpg GRAPHIC 6237
11 GRAPHIC g877593g0917093019883.jpg GRAPHIC 2021
12 GRAPHIC g877593g0917093020514.jpg GRAPHIC 7169
13 GRAPHIC g877593g0917093304241.jpg GRAPHIC 3397
  Complete submission text file 0001193125-24-220556.txt   474182

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20240916.xsd EX-101.SCH 2511
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20240916_lab.xml EX-101.LAB 17956
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20240916_pre.xml EX-101.PRE 11238
24 EXTRACTED XBRL INSTANCE DOCUMENT d877593d8k_htm.xml XML 3723
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 241304709
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)